Skip to main content
Clinical Trials/IRCT20170821035831N2
IRCT20170821035831N2
Completed
未知

?The Evaluatin of Effectiveness of the Milk Testhile for Hepatoxicity in Children with Acute Lymphoblastic Leukemia(ALL)

rmia Medical University0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
rmia Medical University
Enrollment
50
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
rmia Medical University

Eligibility Criteria

Inclusion Criteria

  • ALL diagnosis based on the criteria of the International Institute of Cancer with initial involvement of more than 20% of bone marrow
  • Hepatotoxicity of Grade 2 and 3 in each of the following four cases based on the criteria of the International Institute of Cancer: Aminoalanine Transferase (ALT); Aspartate Aminotransferase (AST); Total Bilirubin (TB)
  • ALL patients in the chemotherapy maintenance phase.
  • ALL patients, 15\-2 years old
  • Patients ALL Pre Bcell, Early Pre Bcell

Exclusion Criteria

  • Unwillingness to participate in the studyl
  • Extra bile duct obstruction, severe liver or kidney failure, gastrointestinal obstruction, malabsorption syndrome, viral hepatitis
  • Grade 4 hepatotoxicity
  • Sepsis\-induced hepatotoxicity
  • Intolerance to Oral Fluoride
  • Deny the patient to study and continue taking the medication
  • No regular and daily intake of medication
  • Gastritis and other complications associated with taking Lourgal
  • History of allergy due to previous use of loroge

Outcomes

Primary Outcomes

Not specified

Similar Trials